| PERIOD ENDING | 2-Jan-09 | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 117,859 | 117,859 | 113,470 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 117,859 | 117,859 | 113,470 | | | Operating Expenses | | Research Development | 257,390 | 257,390 | 225,375 | | Selling General and Administrative | 36,892 | 36,892 | 44,940 | | Non Recurring | 2,890 | 2,890 |
-
| | Others |
-
|
-
| 202 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (179,313) | (179,313) | (157,047) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,505 | 10,505 | 49,991 | | Earnings Before Interest And Taxes | (168,808) | (168,808) | (82,415) | | Interest Expense | 6,762 | 6,762 | 3,966 | | Income Before Tax | (175,570) | (175,570) | (86,381) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest | 12,716 | 12,716 | 24,641 | | | | Net Income From Continuing Ops | (162,854) | (162,854) | (86,381) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (162,854) | (162,854) | (86,381) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($162,854) | ($162,854) | ($86,381) |
|
1.48% Nasdaq 
Income Statement
